MTHFR Gene polymorphisms, B-vitamins and hyperhomocystinemia in young and middle-aged acute myocardial infarction patients

Experimental and Molecular Pathology

Volumn 82, Issue 3, 2007, Pages 227-233

  Angeline, T ^a   Jeyaraj, Nirmala ^a   Tsongalis, Gregory J ^b  

^a LADY DOAK COLLEGE   (India)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Hyperhomocystinemia; MTHFR; Myocardial infarction

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); COBALAMIN; GLUTATHIONE REDUCTASE; HOMOCYSTEINE; RIBOFLAVIN; VITAMIN B GROUP;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DNA POLYMORPHISM; ERYTHROCYTE; FOLIC ACID BLOOD LEVEL; GENE MUTATION; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SPECTROPHOTOMETRY;

ADULT; AGE FACTORS; DIET; DIETARY SUPPLEMENTS; FOLIC ACID; GENE FREQUENCY; GENOTYPE; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RIBOFLAVIN; VITAMIN B 12; VITAMIN B COMPLEX;

EID: 34247596471     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2007.02.005     Document Type: Article

References (32)

1. Balander-Gouaille, C., Bottiglieri, T., 2003. Homocysteine related vitamins and neuropsychiatric disorders. Springer pp. 27.
2. Christensen B., Frosst P., Lussier-Cacan S., Selhub J., Goyette P., Rosenblatt D.S., Genest Jr. J., and Rozen R. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 569-573
3. Devi R.R., Govindaiah V., Ramakrishnan G., and Naushad S.M. Prevalence of methylene tetrahydrofolate reductase polymorphism in South Indian population. Current Science 89 3 (2004) 440-443
4. Esfahani S.T., Cogger E.A., and Caudill M.A. Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J. Am. Diet. Assoc. 103 (2003) 200-207
5. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijmans L.A., ven den Heuvel L.P., and Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10 (1995) 111-113
6. Gašparovič J., Rašlová K., Bašistová Z., Zacharová M., Wsólová L., Avdičová M., Blažíček P., Lietava J., and Siváková D. Effect of C677T methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine levels in ethnic groups. Physiol. Res. 53 (2004) 215-218
7. Gebhardt G.S., Scholtz C.L., Hillermann R., Odendaal H.J., Gebhardt G.S., Scholtz C.L., Hillermann R., and Odendaal H.J. Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentae but not with intrauterine growth restriction. Eur. J. Obstet. Gynecol. Reprod. Biol. 97 (2001) 174-177
8. Gemmati D., Previati M., Serino M.L., Moratelli S., Capitani S., Forini E., Ballerini G., and Scapoli G.L. Low folate levels and thermolabile methylene tetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1761-1767
9. Hanson N.Q., Aras O., Yang F., and Tsai M.Y. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin. Chem. 47 (2001) 661-666
10. Herrmann W., Schorr H., Purschwitz K., Rassoul F., and Richter V. Total homocysteine, vitamin B-12, and total antioxidant status in vegetarians. Clin. Chem. 47 (2001) 1094-1101
11. Isotalo P.A., Wells G.A., and Donnelly J.G. Neonatal and fetal methylene tetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am. J. Hum. Genet. 67 (2000) 986-990
12. Kark J.D., Sinnreich R., Rosenberg I.H., Jacques P.F., and Selhub J. Plasma homocysteine and parental myocardial infarction in young adults in Jerusalem. Circulation 105 (2002) 2725-2729
13. Kluijtmans L.A.J., Kastelein J.J.P., Lindemans J., Boers G.H.J., Heil S.G., Bruschke A.V.G., Jukema J.W., van den Heuvel L.P.W.J., Trijbels F.J.M., Boerma G.J.M., Verheugt F.W.A., Willems F., and Blom H.J. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 96 (1997) 2573-2577
14. Kumagai K., Hiyama K., Oyama T., Maeda H., and Kohno N. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis. Int. J. Mol. Med. 11 (2003) 593-600
15. McNulty H., McKinley M.C., Wilson B., et al. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements. Am. J. Clin. Nutr. 76 (2002) 436-441
16. Morita H., Taguchi J., Kurihara H., Kitaoka M., Kaneda H., Kurihara Y., Maemura K., Shindo T., Minamino T., Ohno M., Yamaoki K., Ogasawara K., Aizawa T., Suzuki S., and Yazaki Y. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 95 (1997) 2032-2036
17. Mukherjee M., Joshi S., Bagadi S., Dalvi M., Rao A., and Shetty K.R. A low prevalence of the C677T mutation in the methylenetetrahydrofolate reductase gene in Asian Indians. Clin. Genet. 61 (2002) 155-159
18. Nygard O., Vollset S.E., Refsum H., Stensvold I., Tverdal A., Nordrehaug J.E., Ueland M., and Kvale G. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274 (1995) 1526-1533
19. Pietrzik K., and Bronstrup A. Homocysteine and cardiovascular diseases Asian Pacific Journal. Clin. Nutr. 5 (1996) 157-160
20. Refsum H., Yajnik C.S., Gadkari M., et al. Hyperhomocystinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am. J. Clin. Nutr. 74 (2001) 233-241
21. Robien K., and Ulrich M.C. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE Minireview. Am. J. Epidemiol. 157 (2003) 571-582
22. Sambrook J., Fritsch E.F., and Maniatis F. Molecular Cloning: A laboratory Manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, ColdSpring Harbor, N.Y.
23. Siri P.W., Verhoef P., and Kok F.J. Vitamins B6, B12 and folate: association with plasma total homocysteine and risk of coronary atherosclerosis. J. Am. Coll. Nutr. 17 (1998) 435-441
24. Song C., Xing D., Tan W., Wei Q., and Lin D. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res. 61 (2001) 3272-3275
25. Strain J.J., Dowey L., Ward M., Pentieva K., and McNulty H. B-vitamins, homocysteine metabolism and CVD. Proc. Nutr. Soc. 63 (2004) 597-603
26. Tietz N.W. Vitamins. In: Burtis C.A., and Ashwood E.R. (Eds). Textbook of Clinical Chemistry. 3rd ed. 29 (1999), WB Saunders, Philadelphia 999-1028
27. Van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., van den Heuvel L.P., and Blom H.J. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am. J. Hum. Genet. 62 (1998) 1044-1051
28. van Guelpen, Bethany. Folate in cancer and cardiovascular disease: prospective studies from the population-based northern Sweden health and disease study. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-850(2006-11-01) Doctoral thesis.
29. Vasisht S., Gulati R., Narang R., Srivastava N., Srivastava L.M., Manchanda S.C., and Agarwal D.P. Polymorphism (C677T) in the 5,10-methyleneterahydrofolate reductase gene: a preliminary study on North Indian men. Indian J. Clin. Biochem. 17 (2002) 99-107
30. Verhoef P., Kok F.J., Kruyssen D.A., Schouten E.G., Witteman J.C., Grobbee D.E., Ueland P.M., and Refsum H. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 989-995
31. Verhoef P., van Vliet T., Olthof M.R., and Katan M.B. A high-protein diet increases postprandial but not fasting plasma total homocysteine concentrations: a dietary controlled, crossover trial in healthy volunteers. Am. J. Clin. Nutr. 82 (2005) 553-558
32. Wiemels J.L., Smith R.N., Taylor G.M., Eden O.B., Alexander F.E., and Greaves M.F. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4004-4009